Home > Publications database > The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate. > print |
001 | 284615 | ||
005 | 20240229155053.0 | ||
024 | 7 | _ | |a 10.1038/s41590-023-01636-5 |2 doi |
024 | 7 | _ | |a pmid:37813964 |2 pmid |
024 | 7 | _ | |a 1529-2908 |2 ISSN |
024 | 7 | _ | |a 1529-2916 |2 ISSN |
024 | 7 | _ | |a altmetric:155263120 |2 altmetric |
037 | _ | _ | |a DKFZ-2023-02034 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Weisshaar, Nina |0 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0 |b 0 |e First author |
245 | _ | _ | |a The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate. |
260 | _ | _ | |a London |c 2023 |b Springer Nature Limited |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1700485108_7064 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2023 Nov;24(11):1921-1932 / #EA:D192#LA:D192# / HI-TRON |
520 | _ | _ | |a The malate shuttle is traditionally understood to maintain NAD+/NADH balance between the cytosol and mitochondria. Whether the malate shuttle has additional functions is unclear. Here we show that chronic viral infections induce CD8+ T cell expression of GOT1, a central enzyme in the malate shuttle. Got1 deficiency decreased the NAD+/NADH ratio and limited antiviral CD8+ T cell responses to chronic infection; however, increasing the NAD+/NADH ratio did not restore T cell responses. Got1 deficiency reduced the production of the ammonia scavenger 2-ketoglutarate (2-KG) from glutaminolysis and led to a toxic accumulation of ammonia in CD8+ T cells. Supplementation with 2-KG assimilated and detoxified ammonia in Got1-deficient T cells and restored antiviral responses. These data indicate that the major function of the malate shuttle in CD8+ T cells is not to maintain the NAD+/NADH balance but rather to detoxify ammonia and enable sustainable ammonia-neutral glutamine catabolism in CD8+ T cells during chronic infection. |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Ma, Sicong |b 1 |
700 | 1 | _ | |a Ming, Yanan |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Madi, Alaa Abdelghani Mohamed |0 P:(DE-He78)f05eabc961bc296c088b3510d6429d02 |b 3 |u dkfz |
700 | 1 | _ | |a Mieg, Alessa |0 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d |b 4 |u dkfz |
700 | 1 | _ | |a Hering, Marvin |0 P:(DE-He78)b099c4255c1bff642f4d338ef157596e |b 5 |u dkfz |
700 | 1 | _ | |a Zettl, Ferdinand |0 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96 |b 6 |u dkfz |
700 | 1 | _ | |a Mohr, Kerstin |0 P:(DE-He78)6c644df06759d9295db52a00eac44c0f |b 7 |u dkfz |
700 | 1 | _ | |a ten Bosch, Nora |0 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff |b 8 |u dkfz |
700 | 1 | _ | |a Stichling, Diana |0 P:(DE-He78)de81d854a499aca413da2a07204b2dfe |b 9 |u dkfz |
700 | 1 | _ | |a Buettner, Michael |b 10 |
700 | 1 | _ | |a Poschet, Gernot |b 11 |
700 | 1 | _ | |a Klinke, Glynis |b 12 |
700 | 1 | _ | |a Schulz, Michael |b 13 |
700 | 1 | _ | |a Kunze-Rohrbach, Nina |b 14 |
700 | 1 | _ | |a Kerber, Carolin |b 15 |
700 | 1 | _ | |a Klein, Isabel Madeleine |b 16 |
700 | 1 | _ | |a Wu, Jingxia |b 17 |
700 | 1 | _ | |a Wang, Xi |b 18 |
700 | 1 | _ | |a Cui, Guoliang |0 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b |b 19 |e Last author |u dkfz |
773 | _ | _ | |a 10.1038/s41590-023-01636-5 |0 PERI:(DE-600)2026412-4 |n 11 |p 1921-1932 |t Nature immunology |v 24 |y 2023 |x 1529-2908 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:284615 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)f05eabc961bc296c088b3510d6429d02 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)b099c4255c1bff642f4d338ef157596e |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)6c644df06759d9295db52a00eac44c0f |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)de81d854a499aca413da2a07204b2dfe |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 19 |6 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-28 |w ger |
915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2023-08-28 |w ger |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT IMMUNOL : 2022 |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-28 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-28 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-28 |
915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b NAT IMMUNOL : 2022 |d 2023-08-28 |
920 | 2 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
920 | 0 | _ | |0 I:(DE-He78)D192-20160331 |k D192 |l T-Zell-Metabolismus |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D192-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|